<DOC>
	<DOCNO>NCT02064075</DOCNO>
	<brief_summary>Purpose : - Vasospasm secondary ischemia follow subarachnoidal hemorrhage considerably affect clinical outcome . The purpose study determine whether crystalloid ( Lactated Ringer 's solution ) colloid ( hydroxyethyl starch ) intravenous infusion effective treatment subarachnoid hemorrhage ( SAH ) Treatment : - Patients randomly divide two group . Depending blood pressure patient member first group receive 15-50 ml/kg Lactated-Ringer 's solution daily part treatment , others 15 ml/kg Lactated-Ringer 's 15-50 ml/kg hydroxyethyl starch solution daily . Measurements : - Neurological status patient determine NIH Stoke Scale Score Glasgow Coma Scale ( GCS ) daily basis . - The mid-term survival quality life evaluate Barthel Index Glasgow Outcome Scale ( GOS ) 14 30 day follow admission clinic . Hypothesis : -The prevalence vasospasms , mortality rate medium-term quality life follow subarachnoid hemorrhage improve patient treat intravenous colloid ( hydroxyethyl starch ) infusion compare intravenous crystalloid infusion .</brief_summary>
	<brief_title>The Mortality Changes Quality Life Patients Suffering From SAH With Different Hydration Strategies</brief_title>
	<detailed_description>Study protocol : - Upon arrival Computed Tomography Angiography ( CTA ) , necessary , four-vessel cerebral angiography carry case patient . Previous medical history obtain particular regard onset symptom premorbid blood pressure value . Afterwards Hunt-Hess classification patient take place . The neurological condition record help NIH Stroke Scale daily basis . An acute delayed open surgery endovascular coiling carry either neurosurgeon interventional neuroradiologist definitive treatment aneurysm . - Patients randomize two group , either treat Lactated Ringer 's hydroxyethyl starch solution . Patients Lactated Ringer 's give 15-50 ml/kg/day Lactated Ringer 's infusion beginning enrollment , member group receive 15 ml/kg Lactated-Ringer 's 15-50 ml/kg hydroxyethyl starch solution daily . The blood pressure exceed 160 mmHg systolic 110 mm Hg mean value prior definitive treatment . After definitive care target blood pressure set ensure clinically optimal state , 150 % premorbid blood pressure , exceed 200/120 mmHg . In order achieve maintain value additional vasoactive drug ( arterenol , dobutrex ) could administer regardless group maximum dose 2.5 micrograms/kg/min arterenol , additional dose 10 ug/kg/min dobutrex necessary , sole intake intravenous solution sufficient . Blood pressure measure invasively , continuously cannulation radial artery . - Neurological status patient determine NIH Stoke Scale Score Glasgow Coma Scale ( GCS ) daily basis . The mid-term survival quality life evaluate Barthel Index Glasgow Outcome Scale ( GOS ) 14 30 day follow admission clinic . - The primary outcome measure study incidence rate vasospasm group , secondary outcome measure include 30-day survival , neurological status GOS score .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>patient subarachnoid hemorrhage patient HuntHess grade IIII . patient HuntHess grade IVV .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Subarachnoid hemorrhage</keyword>
	<keyword>vasospasm</keyword>
	<keyword>Lactated Ringer 's solution</keyword>
	<keyword>Hydroxyethyl starch solution</keyword>
</DOC>